STOCK TITAN

Corvex (MOVE) Financials

MOVE NASDAQ
Trailing 12 months to September 30, 2026
Revenue $9.3M +1857.4% YoY
Net Income -$41.1M n/m YoY
EPS (Diluted) -$21.79 FY2025 annual
Operating Cash Flow -$18.8M n/m YoY
Market Cap $128.0M as of Nov 20, 2026
Price / Sales 13.7x on $9.3M revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 0.2x on $598.3M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MOVE SEC filings page.

Corvex, Inc. (MOVE) reported $9.3M in revenue over the twelve months to Sep 30, 2026, up 1857.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MOVE FY2025

FY2025 shows a development-stage operation with collapsing revenue, deepening gross losses, and liabilities exceeding assets.

Cash conversion changed meaningfully: in FY2025, operating cash flow of -$11.3M was less negative than a net loss of $18.3M, so the accounting loss overstated cash consumption for the period. That differs from FY2024, when operating cash flow of -$22.5M nearly matched the net loss of $23.7M; the latest gap points to non-cash charges or working-capital timing, not cash profitability.

Revenue scale contracted by 57.3% to $433K in FY2025, leaving reported sales far below the company’s operating expense base. Gross economics deteriorated: gross margin was -424.9% versus -196.8% in FY2024, so shrinking sales did not improve the economics of delivery.

Equity moved from positive to negative, falling from $7.4M in FY2024 to -$3.5M in FY2025. Liabilities rose 128.9% while the current ratio fell to 0.6, indicating short-term funding pressure in the reported structure.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Corvex, Inc., because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Altman Z-Score Distress
-43.01

Corvex, Inc. scores -43.01, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $166.4M against total assets of $5.6M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
1/8

Corvex, Inc. passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

Corvex, Inc. reported a net loss of $18.3M while operations used $11.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Corvex, Inc. reported an operating loss of $15.5M against $3.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$5.0M
YoY+6127.5%
QoQ+31.1%

Corvex, Inc. generated $5.0M in revenue in Q3 2026. This represents an increase of 6127.5% from the same quarter a year earlier. Against the prior quarter it is up 31.1%.

EBITDA
-$15.3M
YoYn/m
QoQn/m
5Y CAGRn/m

Corvex, Inc.'s EBITDA was -$15.3M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$17.5M
YoYn/m
QoQn/m
5Y CAGRn/m

Corvex, Inc. reported a net loss of $17.5M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.60

Corvex, Inc. earned -$0.60 per diluted share (EPS) in Q3 2026.

Cash & Balance Sheet

Free Cash Flow
-$16.5M
QoQn/m

Corvex, Inc. recorded an outflow of $16.5M in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$42.0M
YoY+1999.3%
QoQ+93.5%
5Y CAGR+19.6%

Corvex, Inc. held $42.0M in cash against $5.1M in long-term debt as of Q3 2026.

Shares Outstanding
39M

Corvex, Inc. had 39M shares outstanding in Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Return on Equity
-2.9%
QoQ-0.7pp

Corvex, Inc.'s quarterly ROE was -2.9% in Q3 2026: one quarter's net income over shareholder equity, not annualized. Against the prior quarter it is down 0.7 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$1.3M
YoY+13.1%
QoQ-3.4%
5Y CAGR-19.1%

Corvex, Inc. invested $1.3M in research and development in Q3 2026. This represents an increase of 13.1% from the same quarter a year earlier. Against the prior quarter it is down 3.4%.

Capital Expenditures
$9.5M
QoQ+3825.1%

Corvex, Inc. invested $9.5M in capex in Q3 2026, funding long-term assets and infrastructure. Against the prior quarter it is up 3825.1%.

Share Buybacks

Not reported for Q3 2026.

MOVE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOVE quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$5.0M+6127.5%$3.8M+3590.3%$510K+147.6%$44K-50.0%$80K+60.0%$103K+347.8%$206K-75.8%$88K
Cost of RevenueN/AN/AN/A$989K+74.4%$280K-66.9%$362K-4.7%$642K-47.2%$567K
Gross ProfitN/AN/AN/A-$945Kn/m-$200Kn/m-$259Kn/m-$436Kn/m-$479K
R&D Expenses$1.3M+13.1%$1.4M-2.5%$822K-65.2%$809K-59.5%$1.2M-65.7%$1.4M-51.8%$2.4M-18.1%$2.0M-37.4%
SG&A Expenses$15.7M+1179.3%$12.9M+703.6%$3.7M+54.0%$2.7M+20.5%$1.2M-61.5%$1.6M-48.6%$2.4M-4.2%$2.2M-20.9%
Operating Income-$17.4Mn/m-$15.2Mn/m-$4.8Mn/m-$4.4Mn/m-$2.6Mn/m-$3.3Mn/m-$5.2Mn/m-$4.7Mn/m
EBITDA-$15.3Mn/m-$11.7Mn/m-$4.5Mn/m-$4.4Mn/m-$2.6Mn/m-$3.2Mn/m-$5.2Mn/m-$4.7Mn/m
Interest ExpenseN/A$31K$178KN/A$1.5MN/AN/AN/A
Income TaxN/A$20KN/AN/AN/AN/AN/AN/A
Net Income-$17.5Mn/m-$12.8Mn/m-$5.0Mn/m-$5.9Mn/m-$4.0Mn/m-$3.2Mn/m-$5.2Mn/m-$4.6Mn/m
EPS (Basic)-$0.60-$5.12-$3.13-$5.88n/m-$3.49-$3.05-$5.35-$6.05
EPS (Diluted)-$0.60-$5.12-$3.13-$5.88n/m-$3.49-$3.05-$5.35-$6.05
Diluted Shares (Avg)29M3M2MN/A1M1M967,331N/A

MOVE Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOVE quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$627.7M+11195.5%$599.3M+10488.7%$604.5M+7683.7%$5.6M-50.5%$5.6M-63.1%$5.7M-72.8%$7.8M+51.2%$11.3M+20.2%
Current Assets$49.9M+926.3%$28.3M+478.4%$37.9M+448.1%$5.0M-52.0%$4.9M-65.3%$4.9M-75.2%$6.9M+55.6%$10.4M+21.9%
Cash & Equivalents$42.0M+1999.3%$21.7M+928.7%$29.3M+573.2%$2.8M-64.2%$2.0M-82.3%$2.1M-87.5%$4.4M+103.1%$7.9M+29.2%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
InventoryN/AN/A$1.8M-21.3%$1.8M-13.7%$2.5M+21.6%$2.5M+38.5%$2.3M+112.2%$2.0M+83.7%
Accounts Receivable$1.7M$1.6M$1.5MN/AN/AN/AN/AN/A
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$519.2M$519.3M$1.1MN/AN/AN/AN/AN/A
Total Liabilities$29.3M+304.3%$26.1M+548.1%$28.5M+528.4%$9.1M+128.9%$7.3M+50.7%$4.0M-0.6%$4.5M-31.5%$4.0M-33.6%
Current Liabilities$16.2M+133.4%$15.7M+332.3%$17.7M+334.0%$8.8M+155.6%$6.9M+63.6%$3.6M+6.0%$4.1M-38.0%$3.4M-41.6%
Non-Current Liabilities$13.2M+3869.0%$10.4M+2524.2%$10.8M+2253.4%$267K-48.7%$332K-43.1%$396K-36.8%$459K+943.2%$520K+612.3%
Long-Term Debt$5.1MN/AN/AN/AN/AN/AN/AN/A
Total Equity$598.3Mn/m$573.3M+34918.4%$576.0M+17712.2%-$3.5M-147.2%-$1.7M-116.6%$1.6M-90.2%$3.2Mn/m$7.4M+113.3%
Retained Earnings-$201.7Mn/m-$184.2Mn/m-$171.4Mn/m-$166.4Mn/m-$160.5Mn/m-$156.5Mn/m-$153.3Mn/m-$148.1Mn/m

MOVE Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOVE quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$7.0Mn/m-$5.3Mn/m-$4.3Mn/m-$2.3Mn/m-$1.6Mn/m-$3.1Mn/m-$4.3Mn/m-$4.6Mn/m
Depreciation & Amortization$2.1M+5570.3%$3.5M+9324.3%$326K+757.9%$37K-2.6%$37K-24.5%$37K+37.0%$38K-26.9%$38K-5.0%
Stock-Based Compensation$11.3M+1533.4%N/A$2.2M+628.4%N/A$691K+29.4%$250K-83.8%$299K-51.5%N/A
Capital Expenditures$9.5M$243K$6.2MN/AN/AN/AN/A$5K-61.5%
Free Cash Flow-$16.5M-$5.5M-$10.5MN/AN/AN/AN/A-$4.6Mn/m
Investing Cash Flow-$9.8M-$653K$30.4MN/AN/AN/AN/A-$5Kn/m
Financing Cash Flow$37.8M+2419.8%-$1.7M-301.4%$350K-53.8%$3.1M+159.4%$1.5M+1873.7%$848K-96.3%$758K+362.2%$1.2M-67.9%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MOVE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MOVE quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross MarginN/AN/AN/A-2147.7%-250.0%-251.5%-211.7%-544.3%
Operating Margin-350.0%-400.3%-950.4%-10031.8%-3238.8%-3165.0%-2542.7%-5331.8%
Net Margin-351.7%-335.8%-981.4%-13302.3%-5036.3%-3131.1%-2513.6%-5245.5%
Return on Equity-2.9%-2.2%+194.8pp-0.9%+159.2ppN/AN/A-197.0%-160.1pp-160.1%-62.8%+110.0pp
Return on Assets-2.8%+69.7pp-2.1%+54.9pp-0.8%+65.8pp-104.5%-63.7pp-72.5%-24.7pp-57.0%-27.3pp-66.7%+44.7pp-40.8%+22.5pp
Current Ratio3.09+2.4x1.80+0.5x2.14+0.4x0.57-2.4x0.70-2.6x1.35-4.4x1.70+1.0x3.02+1.6x
Debt-to-Equity0.01N/AN/AN/AN/AN/AN/AN/A
Liabilities-to-Equity0.050.05-2.4x0.05-1.4xN/AN/A2.46+2.2x1.400.54-1.2x
Asset Turnover0.010.0x0.010.0x0.000.0x0.010.0x0.010.0x0.020.0x0.03-0.1x0.01
FCF Margin-332.1%-145.2%-2063.9%N/AN/AN/AN/A-5181.8%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$3.5M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.57), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Corvex, Inc. MOVE FY2025 $433K -$18.3M N/A $128.0M —
Alpha Technology Group Limited ATGL FY2025 $951K -$9.0M N/A $126.8M —
Bakkt, Inc. BKKT FY2025 N/A -$107.2M N/A $109.2M —
Swarmer, Inc SWMR FY2025 $310K -$8.5M N/A $134.8M —
Palladyne AI Corp. PDYN FY2025 $5.2M $10.0M N/A $121.6M 36/100
Tucows, Inc TCX FY2025 $390.3M -$75.8M -19.4% $145.1M 22/100

Frequently Asked Questions

Corvex, Inc. (MOVE) reported $433K in total revenue for fiscal year 2025. This represents a -57.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Corvex, Inc. (MOVE) revenue declined by 57.3% year-over-year, from $1.0M to $433K in fiscal year 2025.

No, Corvex, Inc. (MOVE) reported a net loss of $41.1M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $18.3M.

Corvex, Inc. (MOVE) reported diluted earnings per share of -$21.79 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Corvex, Inc. (MOVE) had EBITDA of -$15.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Corvex, Inc. (MOVE) recorded an outflow of $11.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Corvex, Inc. (MOVE) had $5.6M in total assets as of fiscal year 2025, including both current and long-term assets.

Corvex, Inc. (MOVE) invested $5.7M in research and development during fiscal year 2025.

Corvex, Inc. (MOVE) had 1M shares outstanding as of fiscal year 2025.

Corvex, Inc. (MOVE) had a current ratio of 0.57 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Corvex, Inc. (MOVE) had a return on assets of -326.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Corvex, Inc. (MOVE) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $128.0M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Corvex, Inc. (MOVE) trades at 13.7x sales, its market capitalization divided by $9.3M revenue, trailing 12 months to September 30, 2026. The market capitalization is $128.0M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Corvex, Inc. (MOVE) held $2.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $11.3M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Corvex, Inc. (MOVE) has negative shareholder equity of -$3.5M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Corvex, Inc. (MOVE) has an Altman Z-Score of -43.01, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Corvex, Inc. (MOVE) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Corvex, Inc. (MOVE) reported a net loss of $18.3M while operations used $11.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Corvex, Inc. (MOVE) reported an operating loss of $15.5M against $3.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top